News Releases

  • July 24, 2012 Great Lakes Pharmaceuticals, Inc. Announces Initiation of Clinical Study for Antimicrobial Lock Solution, B-Lock™. Beachwood, July 24, 2012 – Great Lakes Pharmaceuticals, Inc. announced today the initiation of the clinical study of the first Company product, the antimicrobial lock solution, B-Lock™. The prospective, randomized, active control clinical investigation is being conducted in 22 clinical ...
  • May 1, 2008 Great Lakes Pharmaceuticals, Inc. Announces $2.4 Million Equity Financing Cleveland, OH, May 1, 2008 – Great Lakes Pharmaceuticals, Inc. announced today the completion of Series A $2.4 million equity financing led by Ohio investment funds including the North Coast Angel Fund JumpStart Inc., Everett Partners, Ltd, Ohio TechAngel Fund and Case Technology Ventures. The Company intends to use ...
  • January 30, 2008 Great Lakes Pharmaceuticals, Inc. Announces the Signing of Exclusive License Agreements Cleveland, Ohio, (January 30, 2008) – Great Lakes Pharmaceuticals, Inc. announced today that it has entered into exclusive license agreements with The Board of Regents of The University of Texas System, acting on behalf of The University of Texas M. D. Anderson Cancer Center (“UTMDACC”), and Wake Forest ...
  • July 26, 2010 Great Lakes Pharmaceuticals, Inc. Announces $3.1 Million Equity Financing Led by Charter Life Sciences CLEVELAND, OH–(Marketwire – July 26, 2010) – Great Lakes Pharmaceuticals, Inc. (“Great Lakes”) announced today the completion of a $3.1 million Series B equity financing led by Charter Life Sciences. More…PDF(90Kb)
  • June 29, 2009 Great Lakes Pharmaceuticals, Inc. announces $2.6 million award from National Institutes of Health Beachwood, OH – (July 29, 2009) – Great Lakes Pharmaceuticals, Inc. announced that the Company has received a Notice of Award from the National Institutes of Health (NIH), National Heart, Lung, And Blood Institute (NHLBI) in support of the project “Development of B-Lock an antibiofilm catheter ...
  • June 30, 2008 Great Lakes Pharmaceuticals, Inc. Receives Fast Track SBIR Grant Award from NIH Beachwood, Ohio – Jun 30, 2008 (PRN): Great Lakes Pharmaceuticals, Inc. announced today that the company has received Phase One, $ 100,000 Fast Track Small Business Innovative Research (SBIR) grant from the National Institute of Health (NIH). More…PDF(71Kb)

GLP Location

Great Lakes Pharmaceuticals, Inc.

2000 Auburn Drive

Suite 200

Beachwood, OH 44122

V: 216.378.7845

F: 216.916.4760